Why it is missed. CO produces non-specific symptoms — headache, nausea, confusion, fatigue — that mimic dozens of other presentations. Standard pulse oximetry cannot distinguish oxyhemoglobin from carboxyhemoglobin. A patient with SpO2 of 98 percent can have a carboxyhemoglobin level of 25 percent and pulse oximetry will not detect it. RT involvement in suspected CO poisoning requires understanding this limitation and advocating for co-oximetry, which measures carboxyhemoglobin directly.
The clinical spectrum. Mild: carboxyhemoglobin 10 to 20 percent — headache, nausea. Moderate: 20 to 40 percent — confusion, syncope, chest pain. Severe: above 40 percent — seizure, coma, myocardial injury, death. CO binds hemoglobin with approximately 240 times the affinity of oxygen and also binds cytochrome oxidase, directly impairing mitochondrial respiration.
The RT treatment role. High-flow 100 percent oxygen via non-rebreather mask is the immediate treatment. At FiO2 1.0, the half-life of carboxyhemoglobin falls from approximately 5 hours on room air to 60 to 90 minutes. For intubated patients, FiO2 1.0 should be maintained until carboxyhemoglobin is confirmed below 5 percent by co-oximetry. Current indications for hyperbaric referral: carboxyhemoglobin above 25 percent, loss of consciousness at any point, neurological symptoms, cardiac dysrhythmia, or pregnancy.
The documentation point: In suspected CO poisoning, document the SpO2 by pulse oximetry and note explicitly that it may be falsely normal due to carboxyhemoglobin. Request co-oximetry if it has not been ordered. A SpO2 of 98 percent in a patient found unconscious in a garage is not reassuring — and the chart should reflect that clinical reasoning.
What it measures. The 6MWT measures the distance a patient can walk in six minutes on a flat, hard surface — a practical assessment of functional exercise capacity reflecting the integrated response of the pulmonary, cardiovascular, musculoskeletal, and neuromuscular systems. It requires no specialized equipment beyond a measured corridor, a pulse oximeter, and a trained administrator.
Clinical utility across diagnoses. COPD: predicts disease severity, exacerbation risk, and mortality better than FEV1 alone in advanced disease — distance below 350 meters is associated with significantly elevated mortality. Pulmonary arterial hypertension: used to assess disease severity and treatment response — a change of 33 meters is the minimal clinically important difference. ILD: tracks progression and guides exercise oxygen prescription. Pre-transplant: baseline exercise capacity for lung and heart transplant candidacy assessment.
RT administration specifics. ATS protocol: 30-meter corridor, 15-minute rest before testing, no warm-up exercise. The RT records: distance walked, SpO2 nadir during the walk, heart rate, dyspnea and fatigue by Borg scale, number of stops, supplemental oxygen used. Desaturation below 88 percent during the test is clinically significant and directly informs exercise oxygen prescription.
The oxygen prescription use case: A patient who desaturates to 85 percent during 6MWT on room air but remains above 90 percent on 2 L/min has a documented indication for exercise oxygen. This specific RT-generated data directly informs the home oxygen prescription and prior authorization documentation. One of the clearest examples of RT-generated data that changes patient treatment.
What a mentor actually provides. Three things that experience alone cannot: a safe relationship to process clinical uncertainty and professional doubt, access to institutional and professional knowledge that is not written down anywhere, and active sponsorship — advocating for the mentee in rooms and conversations the mentee is not in. That last one is the most powerful and the least understood.
How to find a mentor. Identify the RT or clinical leader whose practice, career trajectory, or professional approach you most want to learn from. Ask them directly: “I would like to meet with you monthly to learn from your experience. Would you be willing to do that?” Most experienced practitioners will say yes when asked specifically and respectfully. Most mentorships that do not happen are mentorships that were never directly requested.
How to be a mentor. Every RT with more than five years of clinical experience has something to teach. Mentorship is different from preceptorship — it is a longer-term, less structured relationship focused on professional development. Saying “if you ever want to talk through career questions, I am available” is the opening that most mentorships begin with.
The institutional case: Facilities with active RT mentorship programs have measurably lower RT turnover — which is the single most expensive HR problem in respiratory therapy right now. If your department director needs persuasion: the financial case is available and compelling.
How CMS measures hospital quality. CMS evaluates hospitals through the Hospital-Acquired Condition Reduction Program (HACRP), Hospital Readmissions Reduction Program (HRRP), and Value-Based Purchasing (VBP). Each program ties Medicare reimbursement to specific quality measures. Hospitals that score poorly lose reimbursement. Respiratory therapy outcomes are embedded in several of these measures in ways most RT departments have not formally mapped.
Where RT shows up in CMS metrics. HACRP includes hospital-acquired pneumonia — including VAP. HRRP includes 30-day COPD readmission rates and pneumonia readmission rates as reimbursement-linked measures. VBP includes patient safety measures where ventilator-associated events appear. The RT department’s clinical performance directly affects the hospital’s CMS payment rates.
What RT departments can do with this information. Build internal tracking of VAE rates, COPD 30-day readmission rates, and VAP rates that parallels CMS reporting. The RT director who presents quarterly outcome data linked to CMS reimbursement metrics is speaking the language that hospital finance leadership understands.
Starting point: Ask your hospital’s quality department for the most recent CMS Hospital Compare data for your facility. Find the COPD readmission rate and the HAC scores. Then map the specific RT interventions — COPD discharge education, pulmonary rehab referral, VAP bundle compliance — to those metrics. That connection is your department’s value argument in budget language.
Next: Permissive hypercapnia — when it is appropriate and when it is actively dangerous.
Soon: Pediatric NIV — BiPAP and CPAP specific to neonates and older children.
On deck: Bronchodilator responsiveness testing — what the PFT values mean and how RTs use them clinically.
Staying at the vent,
15 years across academic medical centers & community hospitals
